Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Healthcare Tech Outlook
THANK YOU FOR SUBSCRIBING
Elucent Medical: Modernizing Breast Cancer Care with High- Precision Surgical Navigation
Follow Elucent Medical on :
Ginger Sands, Chief Customer Officer, Elucent Medical
Who decided women don’t deserve the same level of precision available in other forms of cancer care when facing breast cancer surgery? It’s quite a revelation to learn that one in eight women is projected to be diagnosed with breast cancer within their lifetime, out of which a significant percentage will have to undergo surgery. Unfortunately, about 30 percent of these patients will have to face repeat surgery, chiefly due to the general ineffectiveness of the tools used to identify the diseased tissue to be removed, leaving surgeons to rely on guesswork based on mammograms or intraoperative imaging to locate the general area of the tumor during surgery. This leads to incomplete removal of cancer cells, eventually necessitating a second surgery, causing further trauma to patients and driving increased healthcare costs.
Bringing surgical oncologists an intelligent soft tissue marker named SmartClip™ and stereotactic surgical navigation to enable high-precision tumor site detection throughout the surgical removal procedure is Elucent Medical’s focus. Building the EnVisioTM Platform product with a focus on improving clinical outcomes for breast cancer patients, the technology is designed to offer similar surgical navigation used in other oncology specialties that guide oncologists in identifying the precise 3D location of soft tissue cancerous growth in real-time with a state-of-the-art surgical navigation system and precision-guided tools. “We’re enabling cancer surgeons to be more precise in their treatment and modernizing breast cancer care for the 21st century,” says Ginger Sands, Chief Customer Officer at Elucent Medical.
The company’s sophisticated surgical navigation technology is the result of its founder and CEO Laura King’s vision to empower physicians in designing state-of-the-art technology that addresses the real clinical needs. Thus, to improve physician and patient experience, Elucent Medical has developed an innovative solution to address what many surgeons across multiple specialities are facing – how to return to the exact location determined by radiologists who use high-tech, high-cost imaging technology to identify an area of concern.
Elucent Medical’s innovative technology comprises the SmartClipTM Soft Tissue Marker, the EnVisioTM Surgical Navigation System, and the NavSlimTM Navigator device.The SmartClipTM is an implantable grain that is injected into the tumor prior to surgery via a deployment device and enables anatomical localizations to identify the affected area.The grain syncs its electromagnetic (EM) signature pinpointing the precise three-dimensional coordinates identifying the tumor, which is captured by the EnVisioTM Navigation system. The EnVisio system generates an unprecedented EM field of dimensions 50 cm by 50 cm by 35 cm, automatically detecting and translating the 3D analytical image for accurate and reliable guidance from the surgical tools.
To facilitate precise tumor removal, Elucent Medical’s patented Navigator fully integrates with standard hospital handheld electrosurgical tools and displays its movements in real-time on the EnVisioTM Navigation system’s monitor. Aided by the 3D analytical image showcasing the precise location of the SmartClipTM embedded in the tumor, the Navigator enables surgeons to perform minimally invasive surgeries to remove only the cancerous cells, leaving more of healthier tissues intact.
Dr. Richard Bleicher of Fox Chase Cancer Center shares, “Elucent Medical’s advanced surgical navigation technology not only eliminates any guesswork on the surgeons’ part, but also removes the need for additional imaging during surgery. Simultaneously, it contributes to faster tumor removal and quicker patient recovery times with minimal scarring.’’ In a nutshell, Elucent Medical’s technology provides a better experience for both patients and surgeons by significantly reducing repeat surgery rates and diminishing healthcare costs in the long run.
We’re Enabling Cancer Surgeons To Be More Precise In Their Treatment And Modernizing Breast Cancer Care For The 21st Century
Unsurprisingly, the company’s surgical navigation technology has found several early adopters among eminent cancer hospitals and surgeons who experience faster patient treatment and recovery. For example, Philadelphia, PA-based Fox Chase Cancer Center has evaluated and incorporated the company’s technology. As the pioneering surgical navigation technology gains more recognition and acceptance, Elucent Medical looks forward to expanding its application to other soft tissue cancers of the lungs and the colon. With cutting edge precision-guided tools that aid and enhance cancer surgery and radiation therapy, Elucent Medical will continually make the oncologists’ job easier and promote enhanced outcomes for patients.
Management Ginger Sands, Chief Customer Officer, Elucent Medical
Description Elucent Medical provides advanced surgical navigation technology to precisely locate soft tissue cancerous growth in real-time during surgery. The company offers surgical oncologists an intelligent soft tissue marker SmartClip™ and stereotactic surgical navigation to enable high-precision tumor site detection throughout the surgical removal procedure. The company’s EnVisioTM Platform technology improves clinical outcomes for breast cancer patients and is designed to offer similar surgical navigation used in other oncology specialties that guide oncologists in identifying the precise 3D location of the cancerous growth with the state-of-the-art surgical navigation system and precision-guided tools.
This content is copyright protected
However, if you would like to share the information in this article, you may use the link below: